Highlights from the transcatheter cardiovascular therapeutics meeting, September 15-19, 2003, Washington, DC. Best of TCT 2003

David Holmes, Alice K. Jacobs, Norman E. Lepor, Prediman K. Shah, Alan C. Yeung

Research output: Contribution to journalArticle

Original languageEnglish (US)
Number of pages1
JournalReviews in Cardiovascular Medicine
Volume4
Issue number4
StatePublished - Sep 1 2003
Externally publishedYes

Fingerprint

Hyperbaric Oxygenation
Drug-Eluting Stents
Percutaneous Coronary Intervention
Paclitaxel
Chronic Renal Insufficiency
Diabetes Mellitus
Endothelial Cells
Therapeutics
Everolimus
iodixanol

Keywords

  • Chronic kidney disease
  • Contrast-induced nephropathy
  • COOL-MI
  • COURT
  • Diabetes mellitus
  • Drug-eluting stents
  • e-Hepatocyte growth factor
  • ENDEAVOR-I
  • Endothelial cells
  • Everolimus
  • FUTURE II
  • Hyperbaric oxygen therapy
  • Impaired fasting glucose
  • Iodixanol
  • ISAR-SMART II
  • Macrophage immunoreactivity
  • Neovascularity
  • ON-TIME
  • Paclitaxel
  • Percutaneous coronary intervention
  • Polytetrafluoroethylene grafts
  • Power-pulse spra

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Highlights from the transcatheter cardiovascular therapeutics meeting, September 15-19, 2003, Washington, DC. Best of TCT 2003. / Holmes, David; Jacobs, Alice K.; Lepor, Norman E.; Shah, Prediman K.; Yeung, Alan C.

In: Reviews in Cardiovascular Medicine, Vol. 4, No. 4, 01.09.2003.

Research output: Contribution to journalArticle

@article{399b3cb76b3f4fc9b61a6dc9c0bebb81,
title = "Highlights from the transcatheter cardiovascular therapeutics meeting, September 15-19, 2003, Washington, DC. Best of TCT 2003",
keywords = "Chronic kidney disease, Contrast-induced nephropathy, COOL-MI, COURT, Diabetes mellitus, Drug-eluting stents, e-Hepatocyte growth factor, ENDEAVOR-I, Endothelial cells, Everolimus, FUTURE II, Hyperbaric oxygen therapy, Impaired fasting glucose, Iodixanol, ISAR-SMART II, Macrophage immunoreactivity, Neovascularity, ON-TIME, Paclitaxel, Percutaneous coronary intervention, Polytetrafluoroethylene grafts, Power-pulse spra",
author = "David Holmes and Jacobs, {Alice K.} and Lepor, {Norman E.} and Shah, {Prediman K.} and Yeung, {Alan C.}",
year = "2003",
month = "9",
day = "1",
language = "English (US)",
volume = "4",
journal = "Reviews in Cardiovascular Medicine",
issn = "1530-6550",
publisher = "MedReviews LLC",
number = "4",

}

TY - JOUR

T1 - Highlights from the transcatheter cardiovascular therapeutics meeting, September 15-19, 2003, Washington, DC. Best of TCT 2003

AU - Holmes, David

AU - Jacobs, Alice K.

AU - Lepor, Norman E.

AU - Shah, Prediman K.

AU - Yeung, Alan C.

PY - 2003/9/1

Y1 - 2003/9/1

KW - Chronic kidney disease

KW - Contrast-induced nephropathy

KW - COOL-MI

KW - COURT

KW - Diabetes mellitus

KW - Drug-eluting stents

KW - e-Hepatocyte growth factor

KW - ENDEAVOR-I

KW - Endothelial cells

KW - Everolimus

KW - FUTURE II

KW - Hyperbaric oxygen therapy

KW - Impaired fasting glucose

KW - Iodixanol

KW - ISAR-SMART II

KW - Macrophage immunoreactivity

KW - Neovascularity

KW - ON-TIME

KW - Paclitaxel

KW - Percutaneous coronary intervention

KW - Polytetrafluoroethylene grafts

KW - Power-pulse spra

UR - http://www.scopus.com/inward/record.url?scp=0346147018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346147018&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0346147018

VL - 4

JO - Reviews in Cardiovascular Medicine

JF - Reviews in Cardiovascular Medicine

SN - 1530-6550

IS - 4

ER -